Literature DB >> 8514884

Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

C L Achim1, M P Heyes, C A Wiley.   

Abstract

HIV encephalitis is unusual in that neurologic damage occurs in the absence of significant infection of neuronal or glial cells. Because the predominant infected cell in the brain is the macrophage, it has been proposed that release of viral or immune activation factors from macrophages may mediate neurologic damage. Numerous studies have examined the concentration of immune activation factors in the cerebrospinal fluid (CSF), however, there has been no correlation between these CSF measurements and severity of HIV encephalitis (Wiley, C.A., C.L. Achim, R.D. Schrier, M.P. Heyes, J.A. McCutchen, and I. Grant. 1992. AIDS (Phila.). 6:1299-1307. Because CSF measurements may not represent tissue concentrations of these factors, we examined the concentrations of HIV p24, quinolinic acid (QUIN), IL-1, IL-3, IL-6, TNF-alpha, and GMCSF within the brains of 10 AIDS autopsies. Homogenization and extraction of cortical gray, cortical white and deep gray matter showed a good correlation between the amount of HIV gp41 immunostaining and extracted HIV gag protein p24. The concentrations of cytokines were low in the tissue extracts and showed no correlation with severity of HIV encephalitis. Brain extracts from mild cases of HIV encephalitis showed elevated levels of TNF-alpha in deep gray matter, while in more severe cases, elevated TNF-alpha levels were also found within cortical white and cortical gray matter. Brain tissue and CSF QUIN concentrations were substantially increased compared to control values. QUIN concentrations were not correlated with the severity of HIV encephalitis. We conclude that increased tissue levels of TNF-alpha and QUIN may have a role in the etiology of HIV-related neurologic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514884      PMCID: PMC443343          DOI: 10.1172/JCI116518

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

Authors:  S Koenig; H E Gendelman; J M Orenstein; M C Dal Canto; G H Pezeshkpour; M Yungbluth; F Janotta; A Aksamit; M A Martin; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

2.  Anatomical organization of excitatory amino acid receptors and their properties.

Authors:  C W Cotman; D T Monaghan
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

3.  Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

Authors:  D H Gabuzda; D D Ho; S M de la Monte; M S Hirsch; T R Rota; R A Sobel
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

4.  The AIDS dementia complex: II. Neuropathology.

Authors:  B A Navia; E S Cho; C K Petito; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

5.  Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

Authors:  D E Brenneman; G L Westbrook; S P Fitzgerald; D L Ennist; K L Elkins; M R Ruff; C B Pert
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

6.  Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis.

Authors:  C A Wiley; J A Nelson
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

7.  Interleukin-1 immunoreactive innervation of the human hypothalamus.

Authors:  C D Breder; C A Dinarello; C B Saper
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

8.  Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system.

Authors:  W O Whetsell; R Schwarcz
Journal:  Neurosci Lett       Date:  1989-02-27       Impact factor: 3.046

Review 9.  The neuropathology of AIDS. UCLA experience and review.

Authors:  K H Anders; W F Guerra; U Tomiyasu; M A Verity; H V Vinters
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

10.  Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations.

Authors:  M P Heyes; S P Markey
Journal:  Anal Biochem       Date:  1988-10       Impact factor: 3.365

View more
  51 in total

Review 1.  A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.

Authors:  Norman J Haughey; Xiaomao Zhu; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-08       Impact factor: 4.147

2.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors:  E L Sainio; K Pulkki; S N Young
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 3.  Cytokines in the brain during viral infection: clues to HIV-associated dementia.

Authors:  D E Griffin
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

4.  Frequent incorporation of ribonucleotides during HIV-1 reverse transcription and their attenuated repair in macrophages.

Authors:  Edward M Kennedy; Sarah M Amie; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

5.  Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism.

Authors:  Jane Kovalevich; William Yen; Ahmet Ozdemir; Dianne Langford
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-14       Impact factor: 4.147

6.  Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.

Authors:  Cristian L Achim; Anthony Adame; Wilmar Dumaop; Ian P Everall; Eliezer Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-17       Impact factor: 4.147

7.  Molecular and pathologic insights from latent HIV-1 infection in the human brain.

Authors:  Paula Desplats; Wilmar Dumaop; David Smith; Anthony Adame; Ian Everall; Scott Letendre; Ronald Ellis; Mariana Cherner; Igor Grant; Eliezer Masliah
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

8.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.

Authors:  Adarsh M Kumar; J B Fernandez; Elyse J Singer; Deborah Commins; Drenna Waldrop-Valverde; Raymond L Ownby; Mahendra Kumar
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

Review 9.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

10.  Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.

Authors:  Lara Buscemi; David Ramonet; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2007-03-20       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.